Success Stories: A Special Thanks to Premium Processing Service, EB-1A Approved in Just 10 Days for a Life Science Research Professional from India

Client’s Testimonial:

“Thank you all for working on my application and helping assemble a package that got approved on the first try!”

On April 30^th, 2021, we received another EB-1A (Alien of Extraordinary Ability) approval for a Life Science Research Professional 4 in the Field of Biomedical Science (Approval Notice).

General Field: Biomedical Science

Position at the Time of Case Filing: Life Science Research Professional 4

Country of Origin: India

State of Residence at the Time of Filing: California

Approval Notice Date: April 30^th, 2021

Processing Time: 10 days (Premium Processing Requested)

Case Summary:

A life science research professional with an MS in biomedical engineering engaged our expert services to help her present a comprehensive EB-1A (Alien of Extraordinary Ability) petition to the USCIS. When she approached us, as per our job we started evaluating her qualification and research in the field of biomedical science focusing on COVID-19 immunology. Our goal was to deduce that our client’s research addressed some of the world’s most pressing issues, including the treatment of cancer, HIV/AIDS, and COVID-19.

Therefore, we started compiling all the required details to be supplemented in her petition packet, beginning with noting the 12 peer-reviewed scientific articles she published in some of the top-ranked journals in the field, gathering 619 citations from recognized researchers from renowned institutions and organizations around the world. Her work has been cited by researchers in at least 40 countries, thereby confirming that these publications are well-acknowledged and highly relied upon in the biomedical science field. We also specified that our client judged the work of her peers 15 times for some of the recognized journals, supporting the testimony of her actual participation in the scientific community. Furthermore, her study has received funding grants from the National Institutes of Health, the Bill and Melinda Gates Foundation, and Biogen. This funding supports the projects that are beneficial to science and society and to the pursuit of improving public health in particular. Therefore, her research is highly relevant in improving healthcare and public health.

Before sending out the package to USCIS, we needed to add a few recommendation letters. So, we advised her to reach out to her peers for the same. Luckily, four other individuals and leading researchers were obliged to sign the letters, indicating that our client’s work has great power for the progression of research in biomedical science and has implications for fighting the harms of viral infections for public health around the world. According to one of the recommenders:

“Overall, considering her remarkable background and noteworthy history of contributions, [client] is operating at the very top of the field of biomedical science and is positioned to continue her work in propelling the field. It is in the best interests of the field and the United States that her work is sustained.”

Eventually, our team’s efforts and support to her paid off, since we were once again able to prove to the USCIS how our client’s continuing research is of inestimable value to the United States. We thank our client for choosing our law firm and opting for premium processing service, which is a paid option offered by the USCIS that allows petitioners to enjoy accelerated adjudication. Thus, her EB-1A case got approval in just 10 days. We gladly wish her well in her future endeavors.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.